Evaluation of De-O-Acetylated Meningococcal C Polysaccharide-Tetanus Toxoid Conjugate Vaccine in Infancy: Reactogenicity, Immunogenicity, Immunologic Priming, and Bactericidal Activity against O-Acetylated and De-O-Acetylated Serogroup C Strains

Infection and Immunity - Tập 69 Số 4 - Trang 2378-2382 - 2001
Peter Richmond1,2, Ray Borrow3, Jamie Findlow3, Sarah Martin3, Carol A. Thornton4, Keith Cartwright5, Elizabeth Miller1
1Immunisation Division, Communicable Disease Surveillance Centre, Public Health Laboratory Service, London NW9 5EQ,1
2Immunobiology Unit, Institute of Child Health, London WC1N 2AN,2
3PHLS Meningococcal Reference Unit, Withington Hospital, Manchester M20 2LR,3
4Centre for Applied Microbiology and Research, Porton Down, Salisbury SP4 OJG,4 and
5Gloucester Vaccine Evaluation Unit, Public Health Laboratory, Gloucestershire Royal Hospital, Gloucester GL1 3NN,5 United Kingdom

Tóm tắt

ABSTRACT The polysaccharide capsule of serogroup C Neisseria meningitidis (MenC) has been integral to vaccine development. Licensed MenC vaccines contain the O-acetylated (OAc+) form of polysaccharide. Some MenC strains have de-O-acetylated (OAc−) polysaccharide, which may affect antibody specificity and functional activity when used in a vaccine. We evaluated an OAc-MenC conjugate-tetanus toxoid conjugate (MCC-TT) vaccine given concomitantly with whole-cell diphtheria-tetanus-pertussis, Haemophilus influenzae type b, and oral polio immunization in 83 infants at 2, 3, and 4 months of age. Serum bactericidal activities (SBA) against OAc+ and OAc− MenC strains and OAc+ and OAc− polysaccharide-specific immunoglobulin G (IgG) levels were evaluated. MCC-TT vaccine was well tolerated. All infants produced SBA titers of ≥8 after a single dose at 2 months of age. The SBA geometric mean titer for OAc+ strain C11 increased from 2.7 (95% confidence interval [CI] 2.2 to 3.2) to 320 (95% CI, 237 to 432), 773 (95% CI, 609 to 982), and 1,063 (95% CI, 856 to 1319) after one, two, and three doses of MCC-TT, respectively. OAc− IgG levels were twice as high as OAc+ IgG levels after the primary series of MCC-TT vaccine, and the SBA was significantly higher against the OAc− MenC strain. Antibody responses to booster vaccination with either OAc+ MenC polysaccharide vaccine (MACP) or a fourth dose of MCC-TT at 14 months of age provided evidence of immunologic memory. The acetylation status of the booster vaccine influenced the specificity of the response, with significantly higher OAc− IgG levels and SBA after MCC-TT vaccine compared to MACP vaccine but similar OAc+ antibody levels. MCC-TT vaccine is highly immunogenic and primes for immunologic memory against OAc+ and OAc− MenC strains in infancy.

Từ khóa


Tài liệu tham khảo

Anonymous Meningococcal disease falls in vaccine recipients.Commun. Dis. Rep. Wkly.102000133136

10.1128/iai.59.12.4349-4356.1991

10.1056/NEJM197002192820803

10.1016/0264-410X(95)00091-E

10.1016/S0140-6736(96)06392-1

10.1111/j.1574-695X.2000.tb01475.x

10.1111/j.1574-695X.2000.tb01460.x

10.1128/IAI.66.5.2093-2098.1998

10.1093/oxfordjournals.aje.a121176

10.1093/infdis/174.6.1360

10.1128/jcm.32.6.1475-1482.1994

10.1136/bmj.312.7034.817

10.1084/jem.129.6.1307

10.1093/infdis/139.1.52

10.1111/j.1749-6632.1995.tb44461.x

10.1128/CDLI.5.4.479-485.1998

10.1086/315352

10.1093/infdis/175.1.200

10.1001/jama.280.19.1685

10.1128/IAI.66.6.2453-2459.1998

Michon F. Huang C. H. Farley E. K. Hronowski L. Di J. Fusco P. C. Structure activity studies on group C meningococcal polysaccharide-protein conjugate vaccines: effect of O-acetylation on the nature of the protective epitope.Dev. Biol.1032000151160

10.1093/infdis/173.4.1009

10.1017/S0950268899003192

10.1093/infdis/152.4.850

10.2807/esm.02.10.00147-en

10.1086/314753

10.1016/S0264-410X(99)00276-5

10.1086/317646

10.1001/jama.276.14.1181

10.1086/315158

Rubinstein L. J. Stein K. E. Murine immune response to the Neisseria meningitidis group C capsular polysaccharide.II. Specificity. J. Immunol.141198843574362

10.1128/iai.34.1.144-146.1981

Taunay A. E. Feldman R. A. Bastos C. O. Galvao P. A. A. Morais J. S. Castro I. O. Assessment of the protection conferred by anti-group C meningococcal polysaccharide vaccine to 6 to 36 month-old children.Rev. Inst. Adolpho Lutz3819787782